PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Ethanol extracts of seeds significantly reduced fasting blood glucose levels in a dose-dependent manner in streptozotocin-induced diabetic rats [PMID:39714608].
Seed extracts improved cognitive dysfunction in diabetic rats, particularly at 200 mg/kg [PMID:39714608].
P. biglobosa seed extract (100 and 200 mg/kg) was used to determine blood coagulation normalization effects in rats [PMID:36857527].
P. biglobosa seed dose-dependently counteracted the decrease in haemoglobin concentration, packed cell volume, and red blood cell count caused by potassium bromate in rats [PMID:40156815].
Evidence summary
PubMed sources
- 1.PMID: 38673307 (2024) — Contemporary Insights into the Biological Mechanisms of Parkia biglobosa. · International journal of environmental research and public health
- 2.PMID: 41030606 (2025) — Microbial Diversity, Nutritional Composition, and Health Implications of Fermented Locust Bean Seed (Dawadawa) From Ghana. · International journal of food science
- 3.PMID: 36857527 (2023) — Blood Coagulation Normalization Effect of Parkia Biglobosa Seed on Potassium Bromate-induced Coagulopathy. · West African journal of medicine
- 4.PMID: 40156815 (2024) — Abnormal Haematological Profile caused by Potassium Bromate in Wistar Rats is corrected by Parkia biglobosa seed. · Nigerian journal of physiological sciences : official publication of the Physiological Society of Nigeria
- 5.PMID: 37378802